Company news
TrivarX Limited news in 2022
TrivarX Limited's news releases, calls and decks from 2022, newest first.
Medibio Receives R&D Tax Incentive Refund
November 14, 2022
Medibio Appoints CEO
September 19, 2022
Appendix 4E and Preliminary Final Report
August 31, 2022
Sleep Analysis Depressive Burden Study Clinical Trial
July 20, 2022
MEB to Raise $1.4m by way of a Placement & MD/CEO Resigns
June 22, 2022
Reinstatement to Quotation
June 22, 2022
Voluntary Suspension
June 16, 2022
FDA Confirm Diagnostic Method on Depression Validation Trial
May 18, 2022
Medibio Announces Entitlement Offer Result
March 10, 2022
Termination of Underwriting Agreement
March 1, 2022
Non-Renounceable Entitlement Offer Underwriting Update
January 20, 2022